-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, apheresis, Leukemia, bioengineering, Diseases, neurotoxicity, Combinations, Adverse Events, Pediatric, Biological Processes, white blood cells, DNA repair, immune cells, Technology and Procedures, Young Adult, Cell Lineage, Xenograft models, Lymphoid Malignancies, Study Population, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, imaging, flow cytometry, molecular testing, metabolomics, RNA sequencing, pathogenesis, WGS
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Janine Müller, PhD*, Claudia Haferlach, MD, Henning Ruge, PhD*, Heiko Müller, PhD*, Irene Fuhrmann*, Manja Meggendorfer, PhD, Martha-Lena Müller, PhD*, Wolfgang Kern, MD, Torsten Haferlach, MD and Anna Stengel, PhD

MLL Munich Leukemia Laboratory, Munich, Germany

Jamie Oakley, MD1, Evelyn K. Williams, BS2*, Christina Caruso, MD1, Yumiko Sakurai, MSc2*, Reginald Tran, PhD2, Glen Lew, MD3 and Wilbur A. Lam, MD, PhD2

1Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
2Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA
3Aflac Cancer and Blood Disorders Center, Emory Univ. / Children's Healthcare of Atlanta, Atlanta, GA

Keisuke Kato, MD1, Ai Yoshimi, MD1*, Norihito Ikenobe, MD1*, Chie Kobayashi, MD, PhD1,2*, Kazutoshi Koike, MD1* and Masahiro Tsuchida, MD, PhD1*

1Ibaraki Children's Hospital, Mito, Japan
2Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan

Swati S Bhasin, PhD1,2*, Ryan J Summers, MD3, Beena E Thomas4*, Debasree Sarkar, PhD5*, Bhakti Dwivedi, PhD6*, Sunita I Park, M.D.7*, Deborah DeRyckere, BS, PhD8,9, Sharon M. Castellino, MD, MSc10,11,12, Manoj Bhasin, PhD4* and Douglas K Graham, MD, PhD13

1School of Medicine, Emory University, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Atlanta, GA
2Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Atlanta, GA
3Children’s Healthcare of Atlanta/Emory University, Aflac Cancer and Blood Disorders Center, Decatur, GA
4Emory School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, GA
5Emory University, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Atlanta, GA
6Winship Cancer Insitute , Emory School of Medicine, Atlanta, GA
7Department of Pathology, Children's Healthcare of Atlanta, Atlanta, GA
8Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, GA
9Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA, Department of Pediatrics, Emory University, Atlanta, GA, Atlanta, GA
10Aflac Cancer and Blood Disorders Center, Emory University School of Medicine / Children's Healthcare of Atlanta, Atlanta, GA
11Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
12Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
13Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, GA

Nina Rolf, MD, PhD1*, Angela Tsang2*, Lorraine Liu2*, Amanda Lorentzian, BSc3*, Pascal Leclair, MSc4*, Annette Patterson, PhD4*, Philipp Lange, PhD5*, Christopher Maxwell, PhD1*, Chinten J. Lim, PhD1*, Ramon Klein Geltink, PhD5*, Suzanne M. Vercauteren, MD, PhD, FRCPC5 and Gregor S. D. Reid, PhD1

1Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
2BC Children's Hospital, Vancouver, BC, Canada
3Department of Cell Biology, University of British Columbia, Vancouver, BC, Canada
4BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
5Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada

Dikshat Gopal Gupta, MSc1*, Neelam Varma, MD2, Shano Naseem, MD1*, Man Updesh Singh Sachdeva, MD1*, Pankaj Malhotra, MD3, Sreejesh Sreedharanunni, DM1*, Subhash Varma, MD3*, Parveen Bose, MSc1*, Minakshi Gupta, MSc1*, Palak Rana, BSc1*, Yogeshwar Binota, Msc1* and Preeti Sonam, BSc1*

1Department of Hematology, PGIMER, Chandigarh, Post Graduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India
2Department of Hematology, PGIMER, Chandigarh, Post Graduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, UT, India
3Department of Internal Medicine,PGIMER, Chandigarh, Post Graduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India

Rafi Kazi, MD1, Waitman K. Aumann, MD, MS1, Pritha Bagchi, Ph.D2* and Daniel S. Wechsler, MD, PhD1

1Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, GA
2Emory Integrated Proteomics Core (EIPC), Emory University School of Medicine, Atlanta, GA

Akira Nishimura, MD1*, Kazuaki Yokoyama, MD, PhD2, Chika Yamagishi, MD3*, Toshihiko Imamura, MD, PhD4,5, Takuya Naruto, MD, PhD3*, Tomohiro Morio, MD, PhD3*, Yukie Tanaka, PhD6*, Akinori Kanai, PhD7*, Hirotaka Matsui, MD, PhD8*, Naoko Higuchi, MD9*, Akiko Takada, MD10*, Haruna Okuno, MD11*, Shoji Saito, MD, PhD12, Shuhei Karakawa, MD, PhD13*, Shogo Kobayashi, MD14*, Daisuke Hasegawa, MD, PhD15*, Hiroyuki Fujisaki, MD, PhD16*, Daiichiro Hasegawa, MD, PhD17, Kazutoshi Koike, MD, PhD18*, Takashi Koike, MD19*, Shinya Rai, MD, PhD20*, Katsutsugu Umeda, MD, PhD10*, Hideki Sano, MD14*, Yujin Sekinaka, MD, PhD21, Atsushi Ogawa, MD, PhD22*, Akitoshi Kinoshita, MD, PhD23*, Norio Shiba, MD, PhD24, Mizuka Miki, MD25*, Fumihiko Kimura, MD, PhD26, Hideki Nakayama, MD27*, Yozo Nakazawa, MD, PhD28*, Takashi Taga, MD, PhD5,29*, Tomohiko Taki, MD, PhD5,30, Souichi Adachi, MD, PhD5,31, Atsushi Manabe, MD, PhD5,32, Katsuyoshi Koh, MD5,33*, Yasushi Ishida, MD, PhD5,34*, Arinobu Tojo, MD, PhD35 and Masatoshi Takagi, MD, PhD3,5

1Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, TKY, Japan
2Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, TKY, Japan
3Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
4Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan
5Leukemia/Lymphoma Committee of Japanese Society of Pediatric Hematology and Oncology, Tokyo, Japan
6Research Core, Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
7Department of Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
8Department of Molecular Laboratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
9Department of Pediatrics, University of Occupational and Environmental Health, Kitakyushu, Japan
10Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
11Department of Pediatrics, Gunma University Hospital, Maebashi, Japan
12Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, NAG, Japan
13Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan
14Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan
15Department of Pediatrics, St. Luke's International Hospital, Tokyo, JPN
16Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan
17Department of Hematology and Oncology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan
18Division of Pediatric Hematology and Oncology, Ibaraki Children’s Hospital, Mito, Japan
19Department of Pediatrics, Tokai University School of Medicine, Isehara, Japan
20Division of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Osakasayama, Japan
21Department of Pediatrics, National Defense Medical College, Tokorozawa, JPN
22Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan
23Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan
24Department of Pediatrics, Yokohama City University, Yokohama, Japan
25Department of Pediatrics, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan
26Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan
27Department of Pediatrics, Kyushu Cancer Center, Fukuoka, Japan
28Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan
29Department of Pediatrics, Shiga University of Medical Science, Ohtsu, Japan
30Department of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, Japan
31Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
32Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
33Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
34Pediatric Medical Center, Ehime Prefectural Central Hospital, Matsuyama, Japan
35Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo Japan., Tokyo, Japan

Omer Javed, FCPS , DipRCPath1*, Neelum Mansoor, MBBS , FCPS1*, Hamza Khan, MBBS1, Naeem Jabbar, FCPS2*, Talha Israr, MSc1*, Saba Jamal, MBBS, Diplomate American Board of Anatomic and Clinical Pathology, Diplomate American Board of Hematology1* and Fatima Meraj, MBBS, FCPS1*

1Department of Hematology, The Indus Hospital, Karachi, Pakistan
2Department of Pediatric Oncology, The Indus Hospital, Karachi, Pakistan

Teena Bhatla, MD1, Laura Hogan, MD2, Xinxin Xu, MS3*, Lingyun Ji4*, Andrew J Carroll, PhD5, Nyla A Heerema, PhD6, Mary Shago, PhD7*, Lia Gore, MD8, James A. Whitlock, MD9, Stephen P Hunger, MD10, Mignon L. Loh, MD11 and Patrick A. Brown, MD12

1Children's Hospital of New Jersey at Beth Israel Medical Center, Newark, NJ
2Stony Brook Children's, Stony Brook, NY
3Children's Oncology Group, Monrovia, CA
4University of Southern California, Keck School of Medicine, Los Angeles, CA
5Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
6Department of Pathology, The Ohio State University, Columbus, OH
7Cytogenetics Laboratory, The Hospital for Sick Children, Toronto, ON, Canada
8Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado and Children’s Hospital, Aurora, CO
9Hospital For Sick Children, Toronto, ON, CAN
10Department of Pediatrics, Division of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
11Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California Benioff Children’s Hospital, San Francisco, CA
12Johns Hopkins School of Medicine, Baltimore, MD

*signifies non-member of ASH